Who
Sylvie Gregoire
Director and 10% owner
Company insider
Files Form 4 as: Director and 10% owner, CervoMed; Director, Revvity; Director, Cubist Pharmaceuticals; Director, Idm Pharma.
In numbers
- Trades disclosed
- 62
- Buys
- 5
- Sells
- 2
- Bought
- $328K
- Sold
- $1.5M
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 9 Jun 2006
- Last trade
- 8 Jun 2026
- Last filed
- 10 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Jun 2026filed 10 Jun 2026 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,150 at $0.00 | filing |
| 8 Jun 2026filed 10 Jun 2026 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,150 at $0.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 17 Nov 2025filed 19 Nov 2025 | CRVO CervoMedBiotechnology | SEC FORM 4 Bought | $91K10,793 at $8.46 | filing |
| 17 Nov 2025filed 19 Nov 2025 | CRVO CervoMedBiotechnology | SEC FORM 4 Bought | $91K10,807 at $8.46 | filing |
| 14 Nov 2025filed 17 Nov 2025 | CRVO CervoMedBiotechnology | SEC FORM 4 Bought | $13K1,707 at $7.57 | filing |
| 14 Nov 2025filed 17 Nov 2025 | CRVO CervoMedBiotechnology | SEC FORM 4 Bought | $13K1,693 at $7.55 | filing |
| 13 Nov 2025filed 17 Nov 2025 | CRVO CervoMedBiotechnology | SEC FORM 4 Bought | $33K4,447 at $7.51 | filing |
| 12 Nov 2025filed 13 Nov 2025 | CRVO CervoMedBiotechnology | SEC FORM 4 Bought | $41K5,553 at $7.35 | filing |
| 23 Jun 2025filed 25 Jun 2025 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,100 at $0.00 | filing |
| 4 Feb 2025filed 14 Feb 2025 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 14 Jun 2024filed 14 Jun 2024 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,750 at $0.00 | filing |
| 26 Jan 2024filed 26 Jan 2024 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,500 at $0.00 | filing |
| 9 Nov 2023filed 9 Nov 2023 | CRVO CervoMedBiotechnology | SEC FORM 4 Code G | —10,000 at $0.00 | filing |
| 15 Sep 2023filed 15 Sep 2023 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,450 at $0.00 | filing |
| 15 Sep 2023filed 15 Sep 2023 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,500 at $0.00 | filing |
| 15 May 2023filed 17 May 2023 | RVTY RevvityLife-science tools | SEC FORM 4 Code A | —783 at $0.00 | filing |
| 15 May 2023filed 17 May 2023 | RVTY RevvityLife-science tools | SEC FORM 4 Code A | —955 at $0.00 | filing |
| 6 May 2022filed 9 May 2022 | RVTY RevvityLife-science tools | SEC FORM 4 Code A | —610 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.